1. A Case Report of Acute Severe Necrotizing Pancreatitis following the Johnson & Johnson Vaccine against the Novel SARS-CoV-2
- Author
-
Ayrton I. Bangolo, Mahabuba Akhter, Auda Auda, Rahina Akram, Vignesh K. Nagesh, Donnee Athem, Reenu Thomas, Ligaya Tibalan, Mansi Trivedi, Saima Mushtaq, Neha Singh, Pracheta Bagale, Georgemar V. Arana, Tayyaba Khan, Shelja Sharma, Swetha Mynedi, Dhara D. Patel, Mandeep Saini, Madhurya R. Chinthakuntla, Kareem Ahmed, Mary Gad, Srikara Dheer D. R. Gondhi, Georgemar Arana, Rohini B. Gurumoorthy, and Simcha Weissman
- Subjects
General Medicine - Abstract
Acute pancreatitis is an inflammatory condition, which is a leading gastrointestinal cause of hospitalization in the United States. Several conditions are associated with acute pancreatitis. More recently, there have been a few cases reported of acute pancreatitis following the Pfizer-BioNTech COVID-19 mRNA vaccine. To our knowledge, no cases of acute pancreatitis have been yet reported following the Johnson & Johnson’s Janssen COVID-19 vaccine (J& J vaccine). Herein we report a 34-year-old male with no significant past medical history admitted with acute necrotizing pancreatitis, the day following the receipt of the J&J vaccine. Based on the Naranjo and the modified Naranjo scale, the patient met the requirements for probable drug induced pancreatitis. This case report has the objective to raise awareness of a potentially severe side effect of the J&J vaccine. We hope to use this case to support screening all patients for previous history of acute pancreatitis before administration of the J& J vaccine.
- Published
- 2023
- Full Text
- View/download PDF